Elevated risk of lung cancer among people with AIDS

AIDS

Volumn 21, Issue 2, 2007, Pages 207-213

  Chaturvedi, Anil K ^a   Pfeiffer, Ruth M ^a   Chang, Leonard ^a   Goedert, James J ^a   Biggar, Robert J ^a   Engels, Eric A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

CD4; Epidemiology; HIV AIDS; Immunosuppression; Lung cancer; Smoking

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER REGISTRY; CANCER RISK; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION; PREVALENCE; PRIORITY JOURNAL; SMOKING; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CD4 LYMPHOCYTE COUNT; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LUNG NEOPLASMS; MALE; MIDDLE AGED; SMOKING; UNITED STATES;

EID: 33845961961     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3280118fca     Document Type: Article

References (27)

1. Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006; 20:1645-1654.
2. Powles T, Nelson M, Bower M. HIV-related lung cancer - a growing concern? Int J STD AIDS 2003; 14:647-651.
3. Lavole A, Wislez M, Antoine M, Mayaud C, Milleron B, Cadranel J. Lung cancer, a new challenge in the HIV-infected population. Lung Cancer 2005; 51:1-11.
4. Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001; 285:1736-1745.
5. Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C, et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003; 21:3447-3453.
6. Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 2001; 154:544-556.
7. Dal Maso L, Polesel J, Serraino D, Franceschi S. Lung cancer in persons with AIDS in Italy, 1985-1998. AIDS 2003; 17:2117-2119.
8. Bower M, Powles T, Nelson M, Shah P, Cox S, Mandelia S, et al. HIV-related lung cancer in the era of highly active antiretroviral therapy. AIDS 2003; 17:371-375.
9. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005; 97:425-432.
10. Grulich AE, Wan X, Law MG, Coates M, Kaldor JM. Risk of cancer in people with AIDS. AIDS 1999; 13:839-843.
11. Engels EA, Brock MV, Chen J, Hooker CM, Gillison M, Moore RD. Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol 2006; 24:1383-1388.
12. Biggar RJ, Engels EA, Ly S, Kahn A, Schymura MJ, Sackoff J, et al. Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr 2005; 39:293-299.
13. Giordano TP, Kramer JR. Does HIV infection independently increase the incidence of lung cancer? Clin Infect Dis 2005; 40:490-491.
14. Hessol NA, Seaberg EC, Preston-Martin S, Massad LS, Sacks HS, Silver S, et al. Cancer risk among participants in the women's interagency HIV study. J Acquir Immune Defic Syndr 2004; 36:978-985.
15. Phelps RM, Smith DK, Heilig CM, Gardner LI, Carpenter CC, Klein RS, et al. Cancer incidence in women with or at risk for HIV. Int J Cancer 2001; 94:753-757.
16. Parker MS, Leveno DM, Campbell TJ, Worrell JA, Carozza SE. AIDS-related bronchogenic carcinoma: fact or fiction? Chest 1998; 113:154-161.
17. Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA. Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr 2003; 32:527-533.
18. Jemal A, Travis WD, Tarone RE, Travis L, Devesa SS. Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type. Int J Cancer 2003; 105:101-107.
19. Flanders WD, Lally CA, Zhu BP, Henley SJ, Thun MJ. Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: results from Cancer Prevention Study II. Cancer Res 2003; 63:6556-6562.
20. National Cancer Institute, DCCPS Surveillance Research Program Cancer Statistics Branch. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence-SEER 9 Regs Public-Use, NOV 2004 Sub (1973-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission. 4-1-2005.
21. Haiman CA, Stram DO, Wilkens LR, Pike MC, Kolonel LN, Henderson BE, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med 2006; 354:333-342.
22. Burns DN, Kramer A, Yellin F, Fuchs D, Wachter H, DiGioia RA, et al. Cigarette smoking: a modifier of human immunodeficiency virus type 1 infection? J Acquir Immune Defic Syndr 1991; 4:76-83.
23. Schabath MB, Delclos GL, Martynowicz MM, Greisinger AJ, Lu C, Wu X, et al. Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. Am J Epidemiol 2005; 161:412-422.
24. Diaz PT, King MA, Pacht ER, Wewers MD, Gadek JE, Nagaraja HN, et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med 2000; 132: 369-372.
25. Pacht ER, Diaz P, Clanton T, Hart J, Gadek JE. Alveolar fluid glutathione decreases in asymptomatic HIV-seropositive subjects over time. Chest 1997; 112:785-788.
26. Littman AJ, Jackson LA, Vaughan TL. Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 2005; 14:773-778.
27. Engels EA, Frisch M, Biggar RJ, Goedert JJ. Re: "Estimation of risk of cancers before occurrence of acquired immunodeficiency syndrome in persons infected with human immunodeficiency virus". Am J Epidemiol 2003; 157:955-956.